[Breaking] Authorities: "Among 274 patients treated with Remdesivir, a total of 16 deaths"
[Asia Economy Reporter Han Seung-gon] The Central Disease Control Headquarters (CDCH) announced on the 8th that 16 out of 274 patients who received the novel coronavirus (COVID-19) treatment Remdesivir from the U.S. pharmaceutical company Gilead Sciences have died.
According to the CDCH on this day, Remdesivir was administered to 274 patients at 49 hospitals until the 7th. The CDCH emphasized, "It should not be misunderstood that these deaths occurred because Remdesivir was administered."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Gwak Jin, head of the patient management team at the CDCH, stated, "Among the 274 patients, despite receiving the best possible treatment from medical staff including Remdesivir, unfortunately, 16 patients passed away."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
